Papillary Renal Cell Cancer
1 clinical trials · Condition
◉ Watch Papillary Renal Cell Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) (NCT02127710) | AstraZeneca | 2014-04-30 |
Track Papillary Renal Cell Cancer automatically
Every clearance here is in the API, with alerts when new ones post.